P. D. Home

2.2k total citations
48 papers, 1.6k citations indexed

About

P. D. Home is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, P. D. Home has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in P. D. Home's work include Diabetes Management and Research (30 papers), Diabetes Treatment and Management (24 papers) and Metabolism, Diabetes, and Cancer (15 papers). P. D. Home is often cited by papers focused on Diabetes Management and Research (30 papers), Diabetes Treatment and Management (24 papers) and Metabolism, Diabetes, and Cancer (15 papers). P. D. Home collaborates with scholars based in United Kingdom, Denmark and United States. P. D. Home's co-authors include K. G. M. M. Alberti, Henning Beck‐Nielsen, Simon Ashwell, Nigel C. Jones, Giancarlo Viberti, K. G. M. M. Alberti, Jonathan Thow, Ramón Gomis, Michel Komajda and M Hanefeld and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Diabetes Care.

In The Last Decade

P. D. Home

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. D. Home United Kingdom 22 998 428 389 315 180 48 1.6k
R R Williams United States 26 811 0.8× 543 1.3× 348 0.9× 381 1.2× 150 0.8× 62 2.2k
Michael T. McDermott United States 25 1.6k 1.6× 336 0.8× 342 0.9× 199 0.6× 95 0.5× 65 2.2k
Stanley S. Schwartz United States 21 1.4k 1.4× 573 1.3× 671 1.7× 257 0.8× 44 0.2× 64 2.3k
A S Krolewski United States 20 775 0.8× 277 0.6× 297 0.8× 256 0.8× 130 0.7× 29 1.8k
Nicola Sicolo Italy 19 454 0.5× 294 0.7× 369 0.9× 536 1.7× 84 0.5× 67 1.5k
Lawrence I. Rand United States 20 1.1k 1.1× 408 1.0× 317 0.8× 381 1.2× 112 0.6× 35 2.7k
Ralph Ziegler Germany 26 1.3k 1.3× 788 1.8× 153 0.4× 856 2.7× 92 0.5× 130 2.0k
Frank Vercruysse United States 19 1.7k 1.7× 931 2.2× 583 1.5× 199 0.6× 52 0.3× 24 2.1k
Sidsel Arnspang Pedersen Denmark 19 794 0.8× 1.1k 2.5× 208 0.5× 190 0.6× 176 1.0× 69 2.4k
J. K. Lloyd United Kingdom 21 347 0.3× 495 1.2× 330 0.8× 161 0.5× 264 1.5× 36 1.6k

Countries citing papers authored by P. D. Home

Since Specialization
Citations

This map shows the geographic impact of P. D. Home's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. D. Home with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. D. Home more than expected).

Fields of papers citing papers by P. D. Home

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. D. Home. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. D. Home. The network helps show where P. D. Home may publish in the future.

Co-authorship network of co-authors of P. D. Home

This figure shows the co-authorship network connecting the top 25 collaborators of P. D. Home. A scholar is included among the top collaborators of P. D. Home based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. D. Home. P. D. Home is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Home, P. D., Nick Freemantle, Ryuzo Kawamori, et al.. (2013). Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents. UCL Discovery (University College London). 2 indexed citations
2.
Hall, Gillian C., et al.. (2013). Primary‐care observational database study of the efficacy of GLP‐1 receptor agonists and insulin in the UK. Diabetic Medicine. 30(6). 681–686. 22 indexed citations
3.
Komajda, Michel, John J.V. McMurray, Henning Beck‐Nielsen, et al.. (2010). Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. European Heart Journal. 31(7). 824–831. 153 indexed citations
4.
5.
Home, P. D.. (2009). Rapid-acting insulin secretagogues: a clinical need?. Experimental and Clinical Endocrinology & Diabetes. 107(S 04). S115–S119.
6.
Dashora, Umesh, Simon Ashwell, & P. D. Home. (2009). An exploratory study of the effect of using high‐mix biphasic insulin aspart in people with type 2 diabetes. Diabetes Obesity and Metabolism. 11(7). 680–687. 10 indexed citations
7.
Home, P. D.. (2008). HbA1c: the case for using estimated average glucose (eAG). Diabetic Medicine. 25(8). 895–898. 2 indexed citations
8.
Home, P. D. & Giovanni Pacini. (2007). Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin‐sensitizing agents. Diabetes Obesity and Metabolism. 10(9). 699–718. 45 indexed citations
9.
Dashora, Umesh, Latika Sibal, Simon Ashwell, & P. D. Home. (2007). Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo‐controlled trial. Diabetic Medicine. 24(4). 344–349. 12 indexed citations
10.
Ashwell, Simon, et al.. (2006). Twice‐daily compared with once‐daily insulin glargine in people with Type 1 diabetes using meal‐time insulin aspart. Diabetic Medicine. 23(8). 879–886. 89 indexed citations
11.
Home, P. D., et al.. (2005). A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes. Diabetes/Metabolism Research and Reviews. 21(6). 545–553. 56 indexed citations
12.
Home, P. D., SJ Pocock, Henning Beck‐Nielsen, et al.. (2005). Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia. 48(9). 1726–1735. 115 indexed citations
13.
Ashwell, Simon, et al.. (2005). Optimal timing of injection of once‐daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal‐times. Diabetic Medicine. 23(1). 46–52. 42 indexed citations
14.
DeVries, J. Hans, et al.. (2003). A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with Type 1 diabetes. Diabetic Medicine. 20(4). 312–318. 39 indexed citations
15.
Home, P. D.. (1999). [Is the regulation of prandial glucose important in type 2 diabetes?].. PubMed. 25 Suppl 7. 20–1. 1 indexed citations
16.
Home, P. D., et al.. (1992). The effect of intraperitoneal insulin delivery on carbohydrate metabolism in type 1 (insulin-dependent) diabetic patients. Diabetes Research and Clinical Practice. 15(3). 237–244. 7 indexed citations
17.
18.
19.
Francis, Alice J., P. D. Home, I. Hanning, & W. M. G. Tunbridge. (1982). Intermediate acting insulin at bedtime may improve nocturnal diabetic control and reduce post breakfast hyper glycemia. Diabetologia. 23(2). 167. 3 indexed citations
20.
Pickup, John C., P. D. Home, R. W. Bilous, H. Keen, & K. G. M. M. Alberti. (1981). Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.. BMJ. 282(6261). 347–350. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R R Williams Breakdown of academic impact, for papers by Michael T. McDermott Breakdown of academic impact, for papers by Stanley S. Schwartz Breakdown of academic impact, for papers by A S Krolewski Breakdown of academic impact, for papers by Nicola Sicolo Breakdown of academic impact, for papers by Lawrence I. Rand Breakdown of academic impact, for papers by Ralph Ziegler Breakdown of academic impact, for papers by Frank Vercruysse Breakdown of academic impact, for papers by Sidsel Arnspang Pedersen Breakdown of academic impact, for papers by J. K. Lloyd
Rankless by CCL
2026